Ofra Levy-Hacham
Chief Tech/Sci/R&D Officer chez SOL-GEL TECHNOLOGIES LTD.
Profil
Ofra Levy-Hacham is currently the VP-Clinical & Regulatory Affairs at Sol-Gel Technologies Ltd.
He previously worked as the Head-Quality Assurance at Savient Pharmaceuticals, Inc. and as the Vice President-Chemistry & Manufacturing Control at HealOr Ltd.
from 2005 to 2010.
He also served as the Head-Drug Discovery at Geffen Residence & Renewal Ltd.
and as a Project Manager at Biotechnology General (Israel) Ltd.
from 2010 to 2011.
Dr. Levy-Hacham holds a doctorate degree from Technion-Israel Institute of Technology.
Postes actifs de Ofra Levy-Hacham
| Sociétés | Poste | Début |
|---|---|---|
| SOL-GEL TECHNOLOGIES LTD. | Chief Tech/Sci/R&D Officer | 01/01/2011 |
Anciens postes connus de Ofra Levy-Hacham
| Sociétés | Poste | Fin |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | 01/01/2011 |
HealOr Ltd.
 HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Corporate Officer/Principal | 01/01/2010 |
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| GEFFEN RESIDENCE & RENEWAL LTD | Corporate Officer/Principal | - |
Formation de Ofra Levy-Hacham
| Technion-Israel Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| GEFFEN RESIDENCE & RENEWAL LTD | Process Industries |
| Entreprise privées | 3 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
HealOr Ltd.
HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Health Technology |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
